Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending June 2013. The document serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) in the company's ordinary shares, filed pursuant to Rule 13a-16 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a regulatory disclosure regarding executive compensation and does not contain financial performance data.
Material Changes
The filing details a specific transaction involving Mr. S A Hussain, a Person Discharging Managerial Responsibility:
- Event: Vesting of 25% of an award made on June 2, 2008, under the GlaxoSmithKline Deferred Investment Award Plan.
- Date of Vesting: June 2, 2013.
- Payment Details: A cash payment of 1710p per share in respect of 11,888.589 notional Ordinary shares.
- Payment Date: June 20, 2013.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the executive transaction described above.
Investor Verification Points
- Verify the total cash payout amount for Mr. Hussain based on the 1710p per share rate and 11,888.589 notional shares.
- Confirm the payment date of June 20, 2013, for the vested award.
- Review the terms of the GlaxoSmithKline Deferred Investment Award Plan to understand the vesting schedule for awards made in 2008.